Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid.

Schutz, Fabio A B; Bellmunt, Joaquim; Rosenberg, Jonathan E; Choueiri, Toni K

Schutz, Fabio A B; Bellmunt, Joaquim; Rosenberg, Jonathan E; Choueiri, Toni K.

Affiliation

Schutz FA; Dana-Farber Cancer Institute , Harvard Medical School, Boston, MA 02215, USA.

Expert Opin Drug Saf ; 10(4): 645-53, 2011 Jul.

Article in En | MEDLINE | ID: mdl-21524237

Subject(s)

Drug-Related Side Effects and Adverse Reactions/chemically induced; Vinblastine/analogs & derivatives; Vinca Alkaloids/therapeutic use; Animals; Clinical Trials as Topic/methods; Drug Evaluation, Preclinical/methods; Drug-Related Side Effects and Adverse Reactions/metabolism; Humans; Neoplasms/drug therapy; Neoplasms/metabolism; Vinblastine/adverse effects; Vinblastine/pharmacokinetics; Vinblastine/therapeutic use; Vinca Alkaloids/adverse effects; Vinca Alkaloids/pharmacokinetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Vinblastine / Vinca Alkaloids / Drug-Related Side Effects and Adverse Reactions Language: En Journal: Expert Opin Drug Saf Year: 2011 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google